Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Everest Organics Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 409.35 | 1594.79 |
| Expenses | N/A | N/A |
| PBT | 9.49 | -32.42 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 29.13 | -12.9 |
About Everest Organics Ltd.
| Founded | 1993 |
|---|---|
| Managing Director | Sri Kakarlapudi Sirisha |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,46,792.16 | 1,861.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,78,151.98 | 6,705.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,52,914.73 | 4,524.00 | 3,171.90 - 3,171.90 |
| Apollo Hospitals Enterprise Ltd. | 1,23,557.75 | 8,589.50 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,16,353.96 | 1,439.95 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,12,681.23 | 1,351.00 | 1,148.40 - 1,148.40 |
| Zydus Lifesciences Ltd. | 1,09,875.05 | 1,100.70 | 835.50 - 835.50 |
| Max Healthcare Institute Ltd. | 1,09,280.68 | 1,122.85 | 903.00 - 903.00 |
| Lupin Ltd. | 1,07,090.72 | 2,346.00 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,01,632.12 | 2,462.80 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Everest Organics informs about resignation of CS cum CO
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR Regulations’) and the SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, Everest Organics has informed that, Shweta Singh, Company Secretary and Compliance Officer of the company, has tendered her resignation from the position of Company Secretary (CS) and Compliance Officer (CO) of the Company with effect from June 22, 2026, citing personal reasons and better career prospects. The resignation letter (email) of Ms. Shweta Singh has been received by the Company on June 21, 2026 and the same shall be placed before the upcoming Board Meeting for formal acceptance and taking note thereof, in accordance with the applicable provisions of the Companies Act, 2013 and the SEBI LODR Regulations. The details as required under SEBI Circular are enclosed. The Company will make necessary arrangements for appointment of a new Company Secretary and Compliance Officer in accordance with the applicable provisions of law and will intimate the stock exchange(s) accordingly and till such time the Managing Director of the Company will be designated as Compliance Officer of the Company.
The above information is a part of company’s filings submitted to BSE.
Everest Organics informs about press release
Vivo Bio Tech informs about closure of trading window
Mercury Laboratories informs about newspaper advertisement
Sudeep Pharma informs about closure of trading window
Pursuant to the Code of Conduct on Prevention of Insider Trading of the Company and SEBI (Prohibition of Insider Trading) Regulations, 2015, Sudeep Pharma has informed that the trading window for dealing in the securities of the Company shall be closed for designated persons from Wednesday, 1st July 2026 and shall remain closed till 48 hours after the declaration of the un-audited financial results of the Company for quarter ending on 30th June 2026 and other matters, if any. Accordingly, all Designated Persons and their immediate relatives, directly or indirectly, are prohibited to deal in the securities of the Company during this period. The date of the meeting of the Board of directors to approve the un-audited financial results of the company for the aforementioned quarter, shall be informed to the stock exchanges in due course.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Everest Organics Ltd. is ₹266.10 as of 2026-06-25.
The market capitalisation of Everest Organics Ltd. is ₹258.40 as of 2026-06-25.
The 1-year return of Everest Organics Ltd. is -84.35% as of 2026-06-25.
The P/E ratio of Everest Organics Ltd. is 0.00 as of 2026-06-27.
The 52-week high and low of Everest Organics Ltd. are ₹536.40 and ₹197.00, respectively, as of 2026-06-25.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
